Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
Clinical trial NCT07243782 · RECRUITING
Trial details
- NCT number
- NCT07243782
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-22
- Primary completion
- 2027-06-15
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.